Table 6 Taq I B CETP genotypes in various complications of T2DM
CLINICAL COMPLICATION (NO. OF PATIENTS) | GENOTYPE (T2DM PATIENT NO. WITH COMPLICATION/WITHOUT COMPLICATION) | P-VALUE | OR (95% CI) |
|---|---|---|---|
Nephropathy (29) | B1B1 (8/24) | 0.891 | 0.937 (0.365–2.403) |
|  | B1B2 (15/42) | 0.917 | 1.046 (0.449–2.437) |
|  | B2B2 (6/17) | 0.981 | 1.013(0.356–2.879) |
Neuropathy (12) | B1B1 (4/24) | 0.744 | 1.229 (0.338–4.468) |
|  | B1B2 (5/42) | 0.563 | 0.697 (0.205–2.375) |
|  | B2B2 (3/17) | 0.712 | 1.294 (0.316–5.307) |
Retinopathy (9) | B1B1 (3/24) | 0.719 | 1.229 (0.284–5.319) |
|  | B1B2 (4/42) | 1.000 | 0.781 (0.196–3.115) |
|  | B2B2(2/17) | 1.000 | 1.109 (0.211–5.830) |
Hypertension (29) | B1B1 (1/17) | 0.038 | 0.139 (0.018–1.093) |
|  | B1B2 (22/42) | 0.018 | 3.068 (1.183–7.958) |
|  | B2B2 (6/24) | 0.389 | 0.641 (0.232–1.772) |